ARCHIVES

Institutinal Training Awards Hardest Hit As New Budget Cuts Will Slash Into Noncompeting Grants

This article is from The Cancer Letter archive.

Vol. 07 No. 11 | March 13, 1981

Download PDF Visit The Full Archive

Related Articles

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

October 25, 2013

CCIRC Told Group Radiation Studies Cost $20,000 Per 25 Patients

March 14, 1980

Food & Water Inc. Launches ‘Cancer Prevention Campaign’

May 1, 1992

FDA Designates Zometa For Priority Review.

November 30, 2001

NCI advisors approve recompetition of $62 million phase II contracts program.

November 19, 2004

Eleven Chemicals Rated for Tests

September 1, 1978